Skip to content
Alpha Edge Investing

Alpha Edge Investing

"Investors operate with limited funds and limited intelligence, they don’t need to know everything. As long as they understand better than others, they have an edge.” – George Soros

  • Home
  • Earnings Updates/ Corporate Actions
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trust/ ETF
  • News
  • My Opinions/ Views
  • Others
  • About Me
  • Contact
  • Disclaimer
  • Community and Support Forums
  • Toggle search form

CIMB: OCBC – Add Target Price $14.20

Posted on August 9, 2022August 9, 2022 By alanyeo No Comments on CIMB: OCBC – Add Target Price $14.20

NIM above expectations

  • OCBC’s net profit of S$1.48bn in 2Q22 was 10%/11% above our/consensus estimates as NIM grew 16bp on NII increase of 13% qoq.
  • Asset yield turned out to be stronger and likely more sensitive towards the rate rise this time round, in our view.
  • Guidance: positive on FY22 outlook on the back of NII growth from rising rates, loan growth at mid-single-digit %, credit cost at low end of 20-25bp.
2Q22 beat estimates due to stronger NII

? OCBC recorded net profit of S$1.48bn in 2Q22 (+9% qoq, +28% yoy). This was 10%/11% above our/consensus estimates. 1H22 interim DPS of S$0.28 was declared (1H21: S$0.25).

? The beat was mainly the result of stronger-than-expected NIM growth of 16bp to 1.71% vs. our expected 1.64%. NII grew accordingly (+13% qoq). Average asset yields rose 11bp yoy to 2.12% in 1H22 (1H21: 2.01%), outpacing average funding cost growth of 5bp yoy to 0.52% in 1H22 (1H21: 0.47%).

? Non-II held steady in 2Q22 (+3% qoq, +6% yoy) as stronger insurance income (+28% qoq, +67% yoy), higher operating profit and MTM gains in Great Eastern’s insurance funds from higher rates and trading income offset some weakness from wealth management fees (-16% qoq, -25% yoy) and net realised losses from the sale of investment securities.

? On balance, PPOP rose to S$1.6bn in 2Q22 (+13% qoq, +3% yoy). CTI ratio dipped to 43.5% (1Q22: 45.6%).

? Credit costs were in line with expectations at S$78m or 10bp (calculated).

Positive guidance from OCBC

? Growth in Asia remains positive, with economic growth in key markets likely to continue but at slower rates; cautious on near-term headwinds in the operating environment.

? Positive on FY22 outlook as NII growth from rising interest rates is expected to offset near-term pressure on non-II.

? Loan growth on track for mid-single-digit percentage.

? Continue to be disciplined on discretionary spending.

? Credit costs expected to be at low end of guidance (earlier guided for c.20-25bp). Asset quality remains resilient.

Other key highlights

? Loan growth: +1.3% qoq in 2Q22 (1Q22: +1.5% qoq).
? CTI: 43.5% in 2Q22 (1Q21: 50.5%, FY21: 45%).
? NPL ratio: 1.3% in 2Q22 (1Q22: 1.5%) as NPLs in Malaysia and Indonesia eased .
? CET1: 14.9% in 2Q22 (1Q22: 15.5%).
? ROE: 11% in 1H22 (1Q22: 7.5%, FY21: 9.6%).
Reiterate Add and TP of S$14.20
? We project positive share price movement on the back of the beat.

OCBCClick here to Download Full Report in PDF

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
Research - Equities Tags:OCBC

Post navigation

Previous Post: UOBKH: Ascendas REIT – Buy Target Price $3.45 (Previous $3.69)
Next Post: OIR: CDL Hospitality Trusts – Buy Fair Value $1.45

Related Posts

DBS: OCBC – Buy Target Price $15.00 Research - Equities
UOBKH: Oversea-Chinese Banking Corp – Buy Target Price $18.28 Research - Equities
UOBKH: Banking – Singapore (Overweight) Research - Equities
CIMB: OCBC – Add Target Price $13.70 (Previous $15.50) Research - Equities
CIMB: Singapore Banks (Overweight) Research - Equities
Maybank: Singapore Banks Research - Equities
PhillipCapital: Singapore Banking Monthly Research - Equities
Maybank: OCBC Bank – Buy Target Price $14.39 Research - Equities
CIMB: Singapore Banks (Overweight) Research - Equities
Maybank: OCBC Bank – Buy Target Price $14.39 Research - Equities
CIMB: Singapore Banks (Overweight) Research - Equities
PhillipCapital: Singapore Banking Monthly Research - Equities

Leave a Reply

You must be logged in to post a comment.

Login

Log In
Register Lost Password
Get new posts by email
Chat on WhatsApp
  • Earnings Updates/ Corporate Actions
  • My Opinions/ Views
  • News
  • Others
  • Research – Equities
  • Research – Fixed Income/ Bonds
  • Research – Unit Trusts/ ETF

Copyright © 2023 Alpha Edge Investing.

Powered by PressBook Grid Blogs theme